Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...

Recursion Pharmaceuticals RXRX reported a loss of 22 cents per share in the third quarter of 2026, narrower than the Zacks ...

Portal Innovations, a venture development platform supporting early-stage life sciences companies, today announced a strategic partnership with Altitude Lab to strengthen the resources available to ...

Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.

President and Chief Executive Officer - Najat Khan ...

The generosity of strangers has long powered online communities. Spaces like Stack Overflow, GitHub, curl, OpenSSL, Wikipedia ...

Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...

On November 2, 2026, four researchers including Rikiya Takehi from MIT CSAIL (Computer Science and Artificial Intelligence ...

A formalization of Kleene's second recursion theorem in the untyped lambda calculus yields a working Quine, with the proof carried out in the Rocq proof assistant. The approach highlights how the ...

The November 2026 edition of Zcash Monthly covers NU7’s 25-second block upgrade, quantum defenses, Ironwood’s 122,000 ZEC ...

Alphabet Inc. is rated a Buy due to rapid progress in its Gemini Enterprise and TPU system sales businesses. Read more on ...